SH3BP5 and Alzheimer disease: The significant decrease in sAβ content and the absence of SP in the hippocampus and cortex of the FFA3R−/−/APPswe mice were consistent with the correlation of sAβ levels and the synaptic alterations and cognitive dysfunction exhibited by the transgenic AD mice [73,74].